May 31, 2017
Introducing new Executive Director; New funding opportunities
James E. (Jim) Audia, PhD to become Executive Director of CBC as Katie Stallcup Retires
- Jim Audia, currently Chief Scientific Officer of Constellation Pharmaceuticals in Cambridge, Massachusetts, will become Executive Director of the CBC effective August 1, 2017. Dr. Audia succeeds Dr. Kathryn C. (Katie) Stallcup, who will retire in September.
▸ Read more
▸ Press Release
CBC Invites New Catalyst Applications
As the CBC moves into Phase 2, the Catalyst Award program will continue to support basic biomedical research by multi-institutional teams. NEW in Phase 2: projects with translational potential will also be considered. The eligibility requirements and application instructions are included in the revised Catalyst RFA (rev. May 30, 2017) and must be followed. The Fall 2017 Catalyst application round will open at 8AM on Monday, August 14, 2017 and will close at 5PM on Friday, August 18, 2017.
▸ Catalyst RFA (rev. May 30, 2017)
Stay Tuned for Future News from CBC